Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Idera Pharmaceuticals (IDRA) Catches Eye: Stock Rises 8.3%
Idera Pharmaceuticals, Inc. was a big mover last session, as its shares rose over 8% on the day. The upside was driven by a rating upgrade of the company. This also led to far more shares changing hands than in a normal session. Yesterday’s rally reverses the downtrend for the company since Jun 8, as the stock is now down almost 3%.
Over the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesetrday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Idera Pharmaceuticals currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.
Another favorably ranked stock is ANI Pharmaceuticals, Inc. (ANIP - Free Report) , sporting a Zacks Rank #1 (Strong Buy).
Is IDRA going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>